Lucy Therapeutics

Lucy Therapeutics

Biotechnology Research Waltham, Massachusetts, United States 9 employees
Employees
9
Contacts
2
Emails
2
Phones
2

Lucy Therapeutics Overview

Headquarters
Waltham, Massachusetts, United States
Industry
Biotechnology Research
Employees
9
Founded
2017
Funding
12.5M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Lucy Therapeutics

Lucy Therapeutics is a private biotech company focused on developing proprietary small molecule therapies and diagnostic biomarkers using knowledge mapping and mitochondrial expertise to identify and prosecute new targets at the nexus points of genetic, mitochondrial and environmental dysfunction for complex diseases. Our initial focus is on CNS diseases where disease progression is rarely tied to genetics alone and mitochondrial and environmental factors play a bigger role than has been previously thought. LucyTx has identified two separate targets with this approach - one for the orphan disease Rett Syndrome and another for Parkinson’s disease. Our targets have been validated as neuroprotective in multiple animal models and Development Candidates have been identified for both programs. LucyTx is pursuing financing to enter the clinic for these advanced programs.

Lucy Therapeutics Contact Details

People in AeroLeads
3
With contact data
2
Email contacts
2
66.7% coverage
Phone contacts
2
66.7% coverage

Lucy Therapeutics Org Chart

Sample employees and titles
Name Title Contact
George Nikopoulos President & CEO - Biotechnology, Drug
View
Allen Hopper VP Drug Discovery Lucy Therapeutics
Email Phone
Susan L. Koppy Principal of Sl Koppy Consulting, Llc
Email Phone

Employees by Management Level

Senior / Lead 2 profiles
Executive 1 profile
VP / Head 1 profile
Manager 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 1

Lucy Therapeutics Tech Stack

Data / AI 2 profiles

Compare Similar Companies to Lucy Therapeutics